![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, July 06, 2017 8:28:02 AM
Here's what I wrote
Good Morning,
As a stockholder in this company, I have become frustrated with the manner this company is being run. For years we (the stockholders) were told to wait until we got FDA approval. When we got FDA approval, an already diluted share became even more diluted.
Aside from the fact that this is a phenomenal product, there is little reason to believe this company will succeed.
What is the company's plan going forward? What is the company planning to do about the diluted pps? Does the company plan on doing a reverse split anytime soon? Why should I remain optimistic about the operation of this company? Why is the last time (according to the website, anyway) Mr. Staelin directly communicated to shareholders 22Oct2015? To me, there is little compelling evidence to suggest that even the leadership is confident in its product.
I appreciate your time and look forward to hearing back.
Here was the beautiful response I got:
Mr. K: I expect a President’s letter to be issued shortly that will cover the topics you ask about.
Paul Knopick
You wanna talk about a demoralizer...
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM